InnovAge Holding Corp. (INNV) Q3 2026 Earnings Call Transcript
InnovAge Holding Corp. (INNV) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of $0.06. This compares to a loss of $0.08 per share a year ago.
InnovAge (INNV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
InnovAge (INNV) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
InnovAge Holding Corp. (INNV) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
InnovAge Holding Corp. delivers strong operational execution, driving significant revenue and margin expansion through its PACE model for elderly care. INNV's revenue rose 14.7% year-over-year, fueled by participant growth and capitation rate adjustments across established centers. Disciplined cost management and SG&A reductions have expanded center-level contribution margin to 22% and adjusted EBITDA margin to 9.2%.
InnovAge (INNV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
InnovAge Holding Corp. (INNV) Q2 2026 Earnings Call Transcript
InnovAge Holding Corp. (INNV) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to a loss of $0.1 per share a year ago.
InnovAge Holding Corp. (INNV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
InnovAge (INNV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
InnovAge Holding Corp. ( INNV ) Q1 2026 Earnings Call November 4, 2025 5:00 PM EST Company Participants Ryan Kubota - Director of Investor Relations Patrick Blair - Chief Executive Officer Benjamin Adams - Chief Financial Officer Matt Huray - Chief Strategy & Corporate Development Officer Conference Call Participants Benjamin Rossi Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Presentation Operator Good day and thank you for standing by. Welcome to the InnovAge First Quarter 2026 Earnings Conference Call.